Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report.

Digestive Diseases and Sciences
Kentaro ShimizuHisashi Sugimoto

Abstract

The purpose of this study was to evaluate if synbiotic therapy can correct the deteriorated gut flora and environment in patients with severe systemic inflammatory response syndrome (SIRS). Twenty-nine SIRS patients, who fulfilled a serum C-reactive protein (CRP) level >10 mg/dl, received synbiotics (Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides) (S group) and were compared with previous observations in 26 patients without synbiotics (NS group). Analysis of fecal flora confirmed that patients in the S group had significantly greater levels of beneficial Bifidobacterium, Lactobacillus, and total organic acids (particularly short-chain fatty acids) than those in the NS group. The incidence of infectious complications such as enteritis, pneumonia, and bacteremia was significantly lower in the S group than in the NS group. Synbiotics maintain the gut flora and environment and decrease the incidence of septic complications in patients with severe SIRS. Further randomized controlled study is necessary to determine the effects of synbiotics.

References

Oct 1, 1978·The American Journal of Clinical Nutrition·W E MooreL V Holdeman
May 1, 1989·The Journal of Applied Bacteriology·R Fuller
Jan 1, 1984·Journal of Clinical Microbiology·D N Petts
Nov 1, 1980·Applied and Environmental Microbiology·R Tanaka, M Mutai
Sep 1, 1995·Applied and Environmental Microbiology·W E Moore, L H Moore
Dec 1, 1993·Journal of Nutritional Science and Vitaminology·M ItoT Yajima
Mar 1, 1994·Antimicrobial Agents and Chemotherapy·E J Vollaard, H A Clasener
Jan 29, 2000·Immunology and Cell Biology·T Matsuzaki, J Chin
Sep 27, 2001·The Journal of Biological Chemistry·L YinC Giardina
Jan 5, 2002·Scandinavian Journal of Gastroenterology. Supplement·R K LinskensS G Meuwissen
Oct 18, 2002·The Journal of Surgical Research·Akira TsunodaMitsuo Kusano
Nov 28, 2002·Alimentary Pharmacology & Therapeutics·A Hart, M A Kamm
Dec 7, 2002·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Y KanamoriR Tanaka
Dec 14, 2002·FEMS Microbiology Letters·Susan E PrydeHarry J Flint
Feb 14, 2003·Lancet·Francisco Guarner, Juan-R Malagelada
Mar 10, 2004·Springer Seminars in Immunopathology·Bengt Björkstén
May 4, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Qing LiuStephen M Riordan
Jan 8, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Nada RayesPeter Neuhaus
Feb 4, 2006·The Journal of Trauma·Kentaro ShimizuHisashi Sugimoto
Feb 14, 2006·Journal of Bioscience and Bioengineering·Koji Nomoto
Oct 3, 2006·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Peter J WatkinsonJ Duncan Young
Feb 19, 2008·Lancet·Marc Gh BesselinkUNKNOWN Dutch Acute Pancreatitis Study Group

❮ Previous
Next ❯

Citations

Aug 21, 2012·Digestive Diseases and Sciences·Kentaro ShimizuHisashi Sugimoto
Apr 2, 2014·Critical Care : the Official Journal of the Critical Care Forum·Shanmiao GouChunyou Wang
Feb 25, 2014·Medicina clínica·Ismael López de Toro Martín-ConsuegraM Ángeles Arrese-Cosculluela
Mar 9, 2011·Digestive Diseases and Sciences·Mineji HayakawaSatoshi Gando
Apr 26, 2011·Digestive Diseases and Sciences·Joe Alcock
Jan 11, 2014·Expert Opinion on Drug Safety·Tina DidariMohammad Abdollahi
Sep 20, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Stig Bengmark
Aug 4, 2012·International Journal of Antimicrobial Agents·Katerina Kotzampassi, Evangelos J Giamarellos-Bourboulis
Sep 14, 2012·The Quarterly Review of Biology·Joe AlcockChristopher W Kuzawa
Mar 30, 2010·International Journal of Antimicrobial Agents·Ioannis M KoutelidakisKaterina Kotzampassi
Jan 5, 2011·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·K ShimizuH Sugimoto
Oct 12, 2014·Beneficial Microbes·M Van den NieuwboerE Claasen
Dec 4, 2014·Burns : Journal of the International Society for Burn Injuries·Kentaro ShimizuTakeshi Shimazu
Jul 19, 2014·Bioscience, Biotechnology, and Biochemistry·Kimiyuki KanekoMasaharu Onoue
Jun 3, 2016·Middle East Journal of Digestive Diseases·Mohammadreza Mohammad Hoseini-AzarSeyed Mohammad Sadegh Ghafoori
Apr 28, 2018·Current Medical Research and Opinion·Jingzhou MuTonghui Ma
Mar 10, 2016·Antimicrobial Agents and Chemotherapy·Takashi AsaharaKoji Nomoto
Apr 16, 2016·F1000Research·Sunit C Singhi, Suresh Kumar
Sep 16, 2010·International Reviews of Immunology·Ruben HummelenGregor Reid
Sep 15, 2012·Critical Care Medicine·Elaine O PetrofDaren K Heyland
Aug 31, 2020·Acute Medicine & Surgery·Yasutaka NakahoriTakeshi Shimazu
May 23, 2019·Frontiers in Immunology·Felix HaussnerMarkus Huber-Lang
Jan 1, 2014·Journal of Intensive Care·Takako UmenaiToshiyuki Itoi
Sep 29, 2018·Critical Care : the Official Journal of the Critical Care Forum·Kentaro ShimizuTakeshi Shimazu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved